Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (single spun) (4)
• Saliva (3)
• Serum (3)
• Swab medium (2)
• Urine (first morning) (1)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (4)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (3)

Preservation Type

• N/A (1)

Associated Data

• Clinical records (3)
• Followup records (3)
• Microbiological results (3)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (2)
• Pre-analytical data (3)
• Quality indicators (2)
• Survey data (3)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (3)
• 3 - 6 months (1)
• > 6 months (1)

Participant Count

• 11 - 100 (2)
• 101 - 500 (2)
• 1001 - 3000 (1)

Sex

• Both sexes (4)

Age Range

• Child (6 - 12 years) (1)
• Adolescent (12 - 18 years) (1)
• Young adult (18 - 40 years) (3)
• Adult (> 40 years) (1)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (2)

Collection Type

• Disease specific (4)

Consent Restriction

• No Commercial restriction (3)
• No Disease area restriction (4)
• No Genetic analysis restriction (2)
• No Human genetic analysis restriction (3)
• No restrictions (0)
• No Project specific restriction (4)
• No Scope of use restriction (2)

Collection Status

• Completed (2)
• In progress (2)

Access Condition

• Open to applicants (4)

Country

• France (1)
• Kenya (1)
• Peru (1)
• South Africa (1)

County